Results 31 to 40 of about 245,924 (389)

Topical NSAIDs in osteoarthritis [PDF]

open access: yesBMJ, 2004
Best used for short periods during flare-ups in the disease Worldwide, osteoarthritis is the most common disease of synovial joints and also a major cause of locomotor pain and disability.1 Worldwide, symptomatic osteoarthritis, particularly of the knee and hip, has been estimated by the World Health Organization to be the fourth most important cause
Cooper, Cyrus, Jordan, Kelsey M.
openaire   +4 more sources

An update on available pain medications

open access: yesSouth African Family Practice, 2018
Pain is a complex interaction of sensory, emotional and behavioural factors. Chronic pain is among the most common reasons for seeking medical attention.
Elzbieta Osuch, Andre Marais
doaj   +1 more source

To the 100th anniversary of the birth of academician V.A. Nasonova. Pain control in rheumatic diseases: Past and future

open access: yesНаучно-практическая ревматология, 2023
Throughout the history of rheumatology, the attitude to pain has changed significantly. In the XIX and early XX centuries, pain was considered only as one of the symptoms, the control of which is secondary to the etiotropic and pathogenetic therapy of ...
A. E. Karateev
doaj   +1 more source

Nonsteroidal Anti-Inflammatory Drugs and Ectodomain Shedding of the Amyloid Precursor Protein [PDF]

open access: yes, 2008
Background: Epidemiological studies have suggested that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of Alzheimer's disease (AD).
Czirr, Eva   +8 more
core   +1 more source

Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion

open access: yesAdvances in Pharmacological Sciences, 2019
The nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed by medical practitioners in many clinical conditions for the symptomatic treatment of pain and fever.
R. Wong
semanticscholar   +1 more source

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries [PDF]

open access: yes, 2013
PMCID: PMC3570554This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
A Dans   +20 more
core   +3 more sources

COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns

open access: yesPain and Therapy, 2020
Concern about the appropriate role of nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 speculate that NSAIDs, in particular ibuprofen, may upregulate the entry point for the virus, the angiotensin-converting enzyme (ACE) 2 receptors and increase
J. Pergolizzi   +8 more
semanticscholar   +1 more source

Neuropathic pain: targeting the melatonin MT2 receptor

open access: yesSouth African Family Practice, 2016
Neuropathic pain affects a large proportion of the population and reduces a person’s ability to perform optimally. In South Africa, there are a host of factors that hinder the correct diagnosis and treatment of neuropathic pain.
N. Smith, H. Ismail, N. Schellack
doaj   +1 more source

Do NSAIDs and Other Pain Relief Drugs Can Inhibit the Growth of Lactobacillaceae?

open access: yesPolish Journal of Microbiology, 2023
Non-steroidal anti-inflammatory drugs (NSAIDs) commonly used in clinical practice may cause gastrointestinal injuries and influence the gut microbiota.
Kruszewska Hanna   +2 more
doaj   +1 more source

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban. [PDF]

open access: yes, 2020
Background Reducing major bleeding events is a challenge when managing anticoagulation in patients with atrial fibrillation. This study evaluated the impact of modifiable and nonmodifiable bleeding risk factors in patients with atrial fibrillation ...
Amarenco, P   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy